Drugs for Biological Treatment 2026 Tender in Slovakia - 139859854

Procurement Summary

Country: Slovakia

Summary: Drugs for Biological Treatment 2026

Deadline: 25 May 2026

Posting Date: 21 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139859854

Document Ref. No.: 269912-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products
33652000 - Antineoplastic and immunomodulating agents
60000000 - Transport services (excl. Waste transport)

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Part 1: Belimumab Part 2: Abatacept Part 3: Infliximab Part 4: Tocilizumab Part 5: Anifrolumab Part 6: Rituximab The subject of the contract is the supply of drugs for biological treatment. A detailed definition of the subject of the contract is given in section B.1 "Description of the subject of the contract" a B.2 "Commercial conditions of delivery of the subject of the contract", tender documents. The subject of the given part of the subject of the contract is the supply of the drug with the active ingredient Belimumab in accordance with the specification given in part B.1 "Description of the subject of the contract" and B.2 "Commercial conditions of delivery of the subject of the contract", tender documents. The subject of the given part of the subject of the contract is the supply of a medicine with the active substance Abatacept in the sense of the specification given in part B.1 "Description of the subject of the contract" and B.2 "Business conditions of delivery of the subject of the contract", tender documents. The subject of the given part of the subject of the contract is the supply of the drug with the active substance Infliximab in accordance with the specification given in part B.1 "Description of the subject of the contract" and B.2 "Business conditions of delivery of the subject of the contract", tender documents. Subject of the given part the subject of the contract is the supply of a medicine with the active ingredient Tocilizumab in accordance with the specification given in part B.1 "Description of the subject of the contract" and B.2 "Business conditions of delivery of the subject of the contract", tender documents. The subject of the given part of the subject of the contract is the delivery of the medicine with the active substance Anifrolumab in the sense of the specification given in part B.1 "Description of the subject of the contract" and B.2 "Commercial terms of delivery of the subject of the contract", tender documents. The subject of the...
Document Type: Contract Notice Reference Number: 02/2026/NURCH/VS/SC Contract Type: supplies Authority Type: body-pl-cga Doc Title: DRUGS FOR BIOLOGICAL TREATMENT 2026 Dispatch Date: 2026-04-20 Publish Date: 2026-04-21 Submission Date: 2026-05-25

Documents

 Tender Notice